美股市场个股详情

CLDX 塞德斯医疗

添加自选
  • 25.140
  • -0.240-0.95%
收盘价 12/20 16:00 (美东)
  • 25.140
  • 0.0000.00%
盘后 20:01 (美东)
16.68亿总市值-9.74市盈率TTM

关于塞德斯医疗公司

Celldex Therapeutics Inc是一家生物制药公司。它专注于几种免疫治疗技术和其他癌症靶向生物制品的开发和商业化。该公司还从事针对乳腺癌、转移性黑色素瘤、肺癌、实体瘤和卵巢癌的产品的临床试验。其管线产品有Varlilumab、CDX-301、CDX-1140、CDX-0159/Anti-KIT计划和CDX-527。

公司介绍

公司代码CLDX
公司名称塞德斯医疗
上市日期1986/05/01
成立日期1983
CEOMr. Anthony S. Marucci
所属市场纳斯达克
员工数量160
年结日12-31
公司地址Perryville III Building,53 Frontage Road,Suite 220
城市Hampton
省份新泽西
国家美国
邮编08827
电话1-908-454-7120

董事高管

  • 姓名
  • 职务
  • 年薪
  • Anthony S. Marucci
  • Director, President and Chief Executive Officer
  • 836.18万
  • Dr. Tibor Keler, PhD
  • Executive Vice President and Chief Scientific Officer
  • 342.06万
  • Dr. Ronald A. Pepin, PhD
  • Senior Vice President and Chief Business Officer
  • --
  • Elizabeth Crowley
  • Senior Vice President and Chief Product Development Officer
  • --
  • Richard M. Wright, PhD
  • Senior Vice President and Chief Commercial Officer
  • --
  • Dr. Diane C. Young, M.D.
  • Senior Vice President and Chief Medical Officer
  • 296.62万
  • Sam Martin
  • Treasurer, Senior Vice President, Secretary, Principal Accounting Officer and Chief Financial Officer
  • 294.66万
  • Freddy A. Jimenez
  • Senior Vice President and General Counsel
  • --
  • Sarah Cavanaugh
  • Senior Vice President, Corporate Affairs and Administration
  • --
  • Dr. Margo Heath-Chiozzi, M.D.
  • Senior Vice President, Regulatory Affairs
  • 293.70万
  • Karen L. Shoos
  • Chairman of the Board
  • 38.58万
  • Harry H. Penner, Jr
  • Independent Director
  • 37.12万
  • Dr. Rita I. Jain, M.D.
  • Independent Director
  • 59.95万
  • James J. Marino, J.D.,M.B.A.
  • Independent Director
  • 37.74万
  • Dr. Garry A. Neil, M.D.
  • Independent Director
  • 36.62万
  • Herbert J. Conrad
  • Independent Director
  • 36.49万
  • Keith L. Brownlie
  • Independent Director
  • 37.33万
  • Herbert J. Conrad
  • Independent Director
  • --
  • Cheryl L. Cohen
  • Independent Director
  • 36.70万
美股市场投资机会
成长股 成长股

成长股策略挑选具有卓越增长表现的企业。聚焦流通市值≥5亿美元、净利润增长率年报≥15%、毛利率≥50%、净资产收益率年报≥15%且ROE同比增长率>50%的股票,旨在寻找财务状况强劲且成长性极高的公司。 成长股策略挑选具有卓越增长表现的企业。聚焦流通市值≥5亿美元、净利润增长率年报≥15%、毛利率≥50%、净资产收益率年报≥15%且ROE同比增长率>50%的股票,旨在寻找财务状况强劲且成长性极高的公司。